T1	Participants 147 188	large population of hypertensive patients
T2	Participants 361 386	520 hypertensive patients
T3	Participants 837 874	patients receiving two or three drugs
T4	Participants 1155 1162	group L
T5	Participants 1259 1280	hypertensive patients
